RITA Medical Systems to Present at the Salomon Smith Barney

October 24, 2002 at 12:00 AM EDT
RITA Medical Systems to Present at the Salomon Smith BarneyMOUNTAIN VIEW, Calif., Oct. 24 /PRNewswire-FirstCall/ --
RITA Medical Systems, Inc. (Nasdaq: RITA) announced today that it is scheduled to make an investor presentation at the Salomon Smith Barney 2002 Global Health Care Conference on Monday, October 28, 2002 at 4:00 p.m. Eastern Time. The conference is being held October 28-30, 2002 at The Plaza Hotel in New York City.

A live webcast of the Company's presentation at the Salomon Smith Barney Conference will be available via the link http://www.veracast.com/ssb/2002/healthcare/73115434.cfm  .

About RITA Medical Systems, Inc.

RITA Medical Systems develops, manufactures and markets innovative products for patients with solid cancerous or benign tumors.  The proprietary RITA system uses radiofrequency energy to heat tissue to a high enough temperature to ablate it or cause cell death.  While the Company's current focus is on liver cancer and metastatic bone cancer, the Company believes that its minimally invasive technology may in the future be applied to other types of tumors, including tumors of the lung, breast, uterus, prostate and kidney. The Company has received regulatory clearance in major markets worldwide, including the United States.  In March 2000, RITA became the first radiofrequency ablation company to receive specific FDA clearance for unresectable liver lesions in addition to its previous general FDA clearance for the ablation of soft tissue.  In October 2002, RITA again became the first company to receive specific FDA clearance, this time, for the palliation of pain associated with metastatic lesions involving bone.  The Company has sold over 40,000 of its disposable devices throughout the world.

The statements in this news release related to the company's plans to extend its technology to applications beyond the liver are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Information regarding these and other risks is included in the Company's filings with the Securities and Exchange Commission.

RITA is a trademark of RITA Medical Systems, Inc.

For further information, please contact: investors, Matt Clawson, matt@allencaron.com, or media, Len Hall, len@allencaron.com, both of Allen & Caron Inc, +1-949-474-4300, for RITA Medical Systems, Inc.; or Don Stewart, Chief Financial Officer of RITA Medical Systems, Inc., +1-650-314-3400, dstewart@ritamed.com .

Make Your Opinion Count - Click Here

http://tbutton.prnewswire.com/prn/11690X84916664

SOURCE  RITA Medical Systems, Inc.

    -0-                             10/24/2002

/CONTACT:  investors, Matt Clawson, matt@allencaron.com, or media, Len Hall, len@allencaron.com, both of Allen & Caron Inc, +1-949-474-4300, for RITA Medical Systems, Inc.; or Don Stewart, Chief Financial Officer of RITA Medical Systems, Inc., +1-650-314-3400, dstewart@ritamed.com /

/Web site:  http://www.veracast.com/ssb/2002/healthcare/73115434.cfm  /

/Web site:  http://www.ritamedical.com  /

(RITA)

CO:  RITA Medical Systems, Inc.; Salomon Smith Barney
ST:  California, New York
IN:  BIO MTC HEA
SU:  TDS CCA

JN-CM


-- LATH049 --
1781 10/24/2002 07:31 EDT http://www.prnewswire.com